The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study.
Public Health
; 226: 199-206, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38086101
ABSTRACT
OBJECTIVES:
The aim of this study was to describe the global trends in the burden of lymphoma from 1990 to 2019. STUDYDESIGN:
The data used in this study were from the Global Burden of Disease 2019 study.METHODS:
This study described the age-standardised rates of incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) of lymphoma (non-Hodgkin and Hodgkin's lymphoma, NHL and HL, respectively) annually from 1990 to 2019, stratified by sociodemographic index (SDI) and 21 world regions. The estimated annual percentage changes in these indexes were calculated.RESULTS:
In 2019, the age-standardised rates of HL per 100,000 population were lower than those of NHL in terms of incidence (1.1 vs 6.7 per 100,000 person-years, respectively) and prevalence (0.3 vs 5.7 per 100,000 person-years, respectively) but not mortality (21.6 vs 3.2 per 100,000 person-years, respectively). From 1999 to 2019, the global incidence of HL decreased and the incidence of NHL increased, and the prevalence of both HL and NHL increased, but the mortality rates decreased. When stratified by SDI, the incidence of HL decreased in all but middle-SDI regions, the mortality rate of HL decreased in all regions, and both the incidence and mortality rate of NHL increased in all but high-SDI regions. The prevalence of HL and NHL increased in all SDI regions, especially in middle-SDI regions. YLLs and DALYs of HL in all SDI regions and those of NHL in high-SDI regions decreased. YLDs slightly increased in middle- to high-SDI regions.CONCLUSIONS:
Lymphoma remains a major public health issue, and better prevention, precise identification, and promising treatments are vitally important.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Global Burden of Disease
/
Lymphoma
Limits:
Humans
Language:
En
Journal:
Public Health
Year:
2024
Type:
Article
Affiliation country:
China